Related Experiment Video
Updated: May 22, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Cost-benefit analysis of the tsutsugamushi disease prevention program in South Korea
Jinhyun Kim1, Eunhee Lee, Hae-Chun Rhee
1College of Nursing, Research Institute of Nursing Science, Seoul National University, Seoul, South Korea.
Abstract:
The purpose of this research was to evaluate the economic value of the tsutsugamushi disease prevention program and to suggest whether to abolish or expand this program. A cost-benefit analysis was conducted to evaluate the economic feasibility of this prevention program. We collected cost data from 25 public health centers (PHCs) and the medical insurance data for all tsutsugamushi patients. We estimated the costs and benefits of the program using a macro-costing method. The estimated total cost was $1.22 million with a governmental cost of $697,000 and a cost of $521,000 to the PHCs. After the prevention program was implemented, $581 were salvaged from medical costs, $46 from non-medical costs, and $847 from productivity loss due to the reduced number of patients, with an estimated $6.66 million per year in total benefits of the program. The ratio of benefit to cost was found to be 5.5, making the economic value of the program significant. The net benefit should increase if the tsutsugamushi disease prevention program is continued and the implementation period is expanded to 10 years.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Investigation of Disease Outbreaks
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
